Product Description: N9-Isopropylolomoucine is a mitotic cyclin dependent kinase (CDK) inhibitor. N9-Isopropylolomoucine targets CCNB 1/CDK1 and can be used for cancer research[1].
Formula: C17H22N6O
References: [1]Kerry L., et al. Biomarkers indicative of prostate cancer and treatment thereof. Patent. WO2018187478